BioMS Medical to present at BioCentury ... (atements involve risks and uncertainties...)

BioMS Medical to present at BioCentury Conference

Date:3/24/2008

atements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that MBP8298 will continue to demonstrate a satisfactory safety profile in ongoing and future clinical trials; and that BioMS Medical Corp. will complete the respective clinical trials within the timelines communicated in this release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. BioMS Medical Announces 2007 Year End Results
2. BioMS Medical to present at BIO CEO & Investor Conference
3. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
4. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
5. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
6. BioMS Medical announces third quarter 2007 results
7. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
8. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
9. BioMS Medical to present at BioContact 2007
10. BioMS Medical announces its intention to renew a normal course issuer bid
11. SBT Acquisition Inc. Successfully Completes Tender Offer for Shares of Lifecore Biomedical, Inc.

Post Your Comments:

(Date:11/6/2009)...ING VALLEY, Calif., Nov. 6 Calbiot... a Small Business Innovative Research (SBIR) Phase...Material command. Under terms of the agreement, Ca...SRs) for the diagnosis of Dengue virus. ,, D...resents a major threat to military forces deployed...

(Date:11/5/2009)...THERSBURG, Md., Nov. 5 G...inancial results for the third quarter ended Septe...million ($0.04 per share) for the three months end....8 million ($0.08 per share) in the comparable qua...30, 2009, GenVec,s net loss was $14.1 million ($0....

(Date:11/5/2009)...ference Call on Thursday, November 5, 2009 at 4:30...R Nov. 5 /PRNewswire-FirstCall/ - OncoGenex Pharma...SDAQ: OGXI ) today reported unaudited financial r... September 30, 2009 and reviewed the Company,s hig...ollowing consolidated results reflect the operatio...

(Date:11/5/2009)... DIEGO, CA, November 5, 2009 /PRNewswire-FirstCall...used on using proprietary taste receptor-based tec... the food, beverage, and ingredient supply industr...d financial results for the third quarter ended Se...the third quarter of 2009, compared to $4.0 millio...

[0] Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus [0] GenVec Reports Third Quarter 2009 Financial Results [0] OncoGenex Reports Third Quarter 2009 Financial Results [0] SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS

... Praha, Czech Republic www.dataapex.com , ...mer Institute SAV, Bratislava, Slovak Republic, ...tion of MW distribution of polymers by the liquid ...,selective detectors is a simple, affordable sol...development of,synthetic and natural polymers. A...

...mended Cecil Instrument: , Cecil Biocompatib...al biocompatible autosampler which will accommoda...t is required. A fraction collector may be added...is an ion-pair reversed-phase high-performance li...It identifies mutations and polymorphisms based o...

...onomical RNAi screening , , Fl...exible RNAi screening. , FlexiPlate siRNA... scales , in 96-well plates for your choi... select siRNAs and specify plate layout at th... , Advantages of FlexiPlate siRNA: ,...

Other Biology Technology:Practical Aspects of Evaluation of Chromatographic Data in Size Exclusion Chromatography 2 Practical Aspects of Evaluation of Chromatographic Data in Size Exclusion Chromatography 3 Practical Aspects of Evaluation of Chromatographic Data in Size Exclusion Chromatography 4 Practical Aspects of Evaluation of Chromatographic Data in Size Exclusion Chromatography 5 Denaturing HPLC (DHPLC) 2 Denaturing HPLC (DHPLC) 3 FlexiPlate siRNA 2 FlexiPlate siRNA 3 FlexiPlate siRNA 4

Practical Aspects of Evaluation of Chromatographic Data in Size Exclusion Chromatography Denaturing HPLC (DHPLC)FlexiPlate siRNA

(Date:11/5/2009)... training grant in the amount of $2,756,719 by the... Graduation Education and Research Training (IGERT...rded to Kent State. The grant, which is funded und...009, runs through 2014. , The grant funds an IGE...ource sensing (EARS). The purpose of the program i...

(Date:11/4/2009)... Long Beach and Riverside are responsible for a si...ma, and the true impact of air pollution and ship ...mated, according to researchers at the University ...h appears in an online edition of the American Jo...nt of all childhood asthma cases in Long Beach and...

(Date:11/4/2009)... the DNA codes, or genomes, of the famed fugu (or ...ome 10K Project, an international effort to build ...0 species of animals for conducting comparative st...d. , Participating in The Genome 10K project, de...ssue of the Journal of Heredity , are 70 leading ...

Breaking Biology News(10 mins):Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2 USC study finds big air pollution impacts on local communities 2 Singapore scientists join international study of 10,000 vertebrates' genomes 2 Re define 26apos 3BThank You 26apos 3B With Style and Value From Van 26apos 3Bs Gifts 59916 1 Re define 26apos 3BThank You 26apos 3B With Style and Value From Van 26apos 3Bs Gifts 59916 2 Committed Time and Personal Passion 3A Key Traits Among ABL 26apos 3Bs Award Finalists 59912 1 Committed Time and Personal Passion 3A Key Traits Among ABL 26apos 3Bs Award Finalists 59912 2 Committed Time and Personal Passion 3A Key Traits Among ABL 26apos 3Bs Award Finalists 59912 3 Committed Time and Personal Passion 3A Key Traits Among ABL 26apos 3Bs Award Finalists 59912 4 Dr Philip Katz Elected President of the American College of Gastroenterology 59908 1 Dr Philip Katz Elected President of the American College of Gastroenterology 59908 2 Dr Philip Katz Elected President of the American College of Gastroenterology 59908 3

[0] Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing [0] USC study finds big air pollution impacts on local communities [0] Singapore scientists join international study of 10,000 vertebrates' genomes

... take soy or herbal supplements, such as black coh...e, says a Cornell University expert affiliated wit...isk Factors (BCERF) at Cornell, the land-grant ins...o direct evidence that any herbal medicines can in...can have estrogen-like actions and thus raise conc...

...s in the US could soon be asked to approve a human...es a hybrid of the HIV and Ebola viruses. Tests on...he lungs far more efficiently than any other metho...g two killer viruses sounds horrifying, the risks ...anaged to develop an effective form of gene therap...

...rough in human stem cell research, producing embry...tantially speed up the development of treatments f...lities. The discovery made during a project undert...ical Branch and the Synthecon Corporation in the U...icians with an ethical and reliable source of huma...

Other Biology News:Menopause Symptoms May Come Back After Stopping Menopausal Hormone Therapy 2 Menopause Symptoms May Come Back After Stopping Menopausal Hormone Therapy 3 Can two killers make a cure? 2 Insight into the processes of 'positive' and 'negative' learners 2

Menopause Symptoms May Come Back After Stopping Menopausal Hormone Therapy Can two killers make a cure?Insight into the processes of 'positive' and 'negative' learners

...ilZyme AP Conjugate Stabilizer is an aqueous solut...her non-toxic stabilizing chemicals in a MES buffe... This product contains a combination of 0.02% met...preservative. StabilZyme AP Conjugate Stabilizer ...

Mouse Anti-Myoglobin Monoclonal Antibody, Biotin Conjugated, Clone 4E2 from Meridian Life Science, Inc.

... nonspecific binding is a problem in your applicat...vidin products as superior alternatives to avidin ...derivative that combines several key features to p... low nonspecific binding properties. NeutrAvidin d...

BlueView Nucleic Acid Stain from Sigma-Aldrich

Biology Products:

StabilZyme AP Conjugate Stabilizer from SurModics, Inc.Mouse Anti-Myoglobin Monoclonal Antibody, Biotin Conjugated, Clone 4E2 from Meridian Life Science, Inc.UltraLink Immobilized NeutrAvidin from Pierce Biotechnology, Inc.BlueView Nucleic Acid Stain from Sigma-Aldrich

BioMS Medical to present at BioCentury ...(atements involve risks and uncertainties...)